Regenerative Medical Technology (RMTG) Treasury Shares (2021 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Treasury Shares of $133.1 million for Q1 2026, up 90.18% year-over-year from $70.0 million in Q1 2025, and little changed quarter-over-quarter from $133.1 million in Q4 2025.
Regenerative Medical Technology (RMTG) Treasury Shares (2021 - 2026) Analysis & Trends
Regenerative Medical Technology's Treasury Shares history runs 6 years deep, the most recent figure standing at $133.1 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 90.18% year-over-year to $133.1 million; the TTM figure through Mar 2026 stood at $133.1 million (up 90.18% YoY), while the FY2025 annual figure was $133.1 million, up 90.18% from the prior year.
- Treasury Shares for Q1 2026 stood at $133.1 million, roughly flat from $133.1 million in the prior quarter.
- The five-year high for Treasury Shares was $133.1 million in Q4 2025, with the low at $70.0 million in Q3 2024.
- The 5-year median for Treasury Shares is $87.5 million (2023), against an average of $98.0 million.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares surged 9757.14% in 2022, then dropped 20.0% in 2024.
- Regenerative Medical Technology's Treasury Shares stood at $103.5 million in 2022, then retreated by 15.46% to $87.5 million in 2023, then slipped by 20.0% to $70.0 million in 2024, then surged by 90.18% to $133.1 million in 2025, then changed by 0.0% to $133.1 million in 2026.
- Business Quant data shows RMTG's Treasury Shares at $133.1 million in Q1 2026, $133.1 million in Q4 2025, and $132.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.13 Mn |
| Mar 31, 2026 | 133.13 Mn |
| Dec 31, 2025 | 133.13 Mn |
| Dec 31, 2025 | 133.13 Mn |
| Sep 30, 2025 | 132.53 Mn |
| Sep 30, 2025 | 132.53 Mn |
| Jun 30, 2025 | 82.53 Mn |
| Jun 30, 2025 | 82.53 Mn |
| Mar 31, 2025 | 70.00 Mn |
| Mar 31, 2025 | 70.00 Mn |
| Dec 31, 2024 | 70.00 Mn |
| Dec 31, 2024 | 70.00 Mn |
| Sep 30, 2024 | 70.00 Mn |
| Sep 30, 2024 | 70.00 Mn |
| Dec 31, 2023 | 87.50 Mn |
| Dec 31, 2023 | 87.50 Mn |
| Dec 31, 2022 | 103.50 Mn |
| Dec 31, 2022 | 103.50 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Dec 31, 2021 | 1.05 Mn |